Metraipolis › archive › dc_8760dd74fbb3
Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy — Europe PMC PMID:41304874
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41304874
- DOI
- 10.3390/ph18111628
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T23:57:09.426Z
- SHA-256 of the archived text
c49b50eaab595b8dd220b0784b8b542afb23a37b92e630be3b488c79bfe88b82- Stable URL of this page
https://metraipolis.com/documento/dc_8760dd74fbb3
How to cite
Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy — Europe PMC PMID:41304874 — Europe PMC (en), https://europepmc.org/article/MED/41304874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8760dd74fbb3 (Metraipolis archive dc_8760dd74fbb3, sha256 c49b50eaab595b8dd220b0784b8b542afb23a37b92e630be3b488c79bfe88b82)
BibTeX
@misc{dc8760dd74fbb3,
title = {Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy — Europe PMC PMID:41304874},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41304874},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8760dd74fbb3; sha256 c49b50eaab595b8dd220b0784b8b542afb23a37b92e630be3b488c79bfe88b82},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304874. Agents can read the archived copy with the MCP tool read_document.